Dr. Low Wang, MD, FACP, is an endocrinologist and Professor of Medicine at University of Colorado, and Lead Clinician-Scientist at CPC Clinical Research. She is a voting member of the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee. After completion of her medical and research training, she joined the faculty at University of Colorado, continuing her clinical work in endocrinology and internal medicine, and basic research investigating insulin action in the vascular wall with a focus on mechanisms of atherosclerosis in insulin resistance at the Denver Veterans Affairs Medical Center. She became Associate Director for Fellowship/Education for the Division of Endocrinology, Metabolism and Diabetes, and the Director of the Glucose Management Team at the University of Colorado Hospital. She served as a panel member of the Colorado Multiple Institutional Review Board for several years. Dr. Low Wang designs and helps run clinical trials for drugs, devices and biologics. She adjudicates major adverse cardiovascular and limb events and bleeding end points for an international multicenter trial, and is the Medical Safety Officer for several national trials. Her clinical research interests include innovative approaches in clinical trials, pharmacovigilance, the development of novel therapies, inpatient hyperglycemia, and cardiovascular disease in diabetes.

She has a strong track record in medical education and has served on multiple committees for the Endocrine Society; she also reviews for journals in the diabetes, endocrinology, cardiovascular and hospital medicine fields and has extensive experience publishing, speaking/teaching, and chairing sessions for the Endocrine Society, American Diabetes Association and other professional organizations. She sees endocrine patients in the outpatient and inpatient settings with a focus on diabetes, complications of diabetes, insulin resistance, and lifestyle management for metabolic disease.

Dr Mathes earned his MD at Tulane University Medical School and went on to surgery training at New York Presbyterian Hospital, Weill‐Cornell Medical Center and served as a research fellow at Massachusetts General Hospital, Harvard Medical School. He completed his plastic surgery training at University of Texas, Southwestern Medical Center. He has served as an Associate Professor of Surgery at the University of Washington SOM and Chief of Plastic Surgery Service at the VA Puget Sound Health Care System in Seattle and continues to practice at the Rocky Mountain Regional VA Center. He was promoted to Professor of Surgery and Division Chief of Plastic and Reconstructive Surgery with the University of Colorado School of Medicine. He was elected to serve on the American Society of Plastic Surgery Board of Directors for 2020. His clinic/research interests include microsurgical reconstruction and composite tissue transplantation with minimal immunosuppression.

Dr. Tae Chong is a board certified plastic surgeon and Associate Professor in the Division of Plastic Surgery at the University of Colorado. He specializes in reconstructive surgery with a focus on microsurgery, wound healing, and limb salvage. Prior to joining the faculty at the University of Colorado, Dr. Chong was the director of reconstructive surgery at Parkland Hospital and was the associate program director at the University of Texas Southwestern (Dallas). There he was the medical director for the wound care fellowship.

Dr. Chong trained in general surgery at the University of Virginia and spent an additional two years in research fellowship in transplantation. He then completed his plastic surgery training at the University of Pittsburgh.

At the University of Colorado, Dr. Chong’s research aligns with his clinical interests in wound healing, microsurgery, and limb salvage. He provides the latest innovations in reconstructive surgery including perforator flaps, super microsurgery (lymphaticovenous bypass) for the management of lymphedema, and the use of novel wound healing adjuncts. He is the PI on several research projects on scarring and wound healing.